Novartis loses new bid to dismiss U.S. lawsuit over kickbacks | Business Information & News | Westlaw

Novartis loses new bid to dismiss U.S. lawsuit over kickbacks | Business Information & News | Westlaw

View on Westlaw or start a FREE TRIAL today, Novartis loses new bid to dismiss U.S. lawsuit over kickbacks, Business Information & News
8/8/14 REUTERS 11:21:15
REUTERS
Copyright © 2014 Thomson Reuters
August 8, 2014
Novartis loses new bid to dismiss U.S. lawsuit over kickbacks
Jonathan Stempel
NEW YORK (Reuters) - A Manhattan federal judge on Thursday said the U.S. Department of Justice may pursue most of its lawsuit accusing Novartis AG of civil fraud for allegedly using kickbacks to boost sales of drugs covered by Medicare and Medicaid....
---- Index References ----
Company: BIOSCRIP INC; NOVARTIS INC; NOVARTIS PHARMACEUTICALS CORP
News Subject: (Major Corporations (1MA93); U.S. Medicare & Medicaid (1ME80))
Industry: (Pharmaceuticals (1PH33); Healthcare (1HE06); U.S. National Healthcare Reform (1US09); Healthcare Regulatory (1HE04); Nephrology (1NE51); Urology (1UR82); Pharmaceuticals & Biotechnology (1PH13); Healthcare Practice Specialties (1HE49); Health Insurance (1HE18); Internal Medicine (1IN54))
Region: (USA (1US73); New York (1NE72); Western Europe (1WE41); Americas (1AM92); North America (1NO39); North Carolina (1NO26); U.S. Southeast Region (1SO88); Central Europe (1CE50); Switzerland (1SW77); U.S. Mid-Atlantic Region (1MI18); Europe (1EU83))
Language: EN
Other Indexing: (Care Act; Colleen McMahon; Julie Masow; David Kester; Preet Bharara)
Keywords: antitrust; health (MCC:f); (N2:US); (N2:AMERS); (N2:USA); (MCCL:OVR)
Word Count: 525
End of Document© 2024 Thomson Reuters. No claim to original U.S. Government Works.